Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changzhou Ruihui Chemical is a Chinese chemical manufacturing company that specializes in the production of fine chemicals and pharmaceutical intermediates. Established in 2013 and headquartered in Changzhou, Jiangsu Province, the company provides a variety of chemical building blocks used in the synthesis of active pharmaceutical ingredients (APIs) and other specialty applications. Its product portfolio includes compounds such as 4'-chloro-3,4-dihydroxybenzophenone and pyridoxine tripalmitate, which are utilized in the pharmaceutical and cosmetic industries. As a supplier to the global life sciences market, Changzhou Ruihui Chemical focuses on delivering high-purity reagents and custom synthesis services to support drug discovery and development. The company operates as a private entity and serves as a key link in the pharmaceutical supply chain by providing essential raw materials for complex chemical synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changzhou Ruihui Chemical.